MagicMed’s Natalie Dolphin: PsyAI™ Designed to Streamline Pharmaceutical Design

- March 19th, 2021

Psychedelic Finance recently interviewed MagicMed Executive Natalie Dolphin about the company’s proprietary PsyAI™ and the Psybrary™.

Psychedelic Finance recently interviewed MagicMed Executive Natalie Dolphin about the company’s proprietary PsyAI™ and the Psybrary™. In the interview, Dolphin likens PsyAI™ to a key and mental health indications a lock, whereby MagicMed, “creates a large library of potential keys.”

MagicMed’s Psybrary™ is designed to become one of the leading providers of novel drug candidates for the biotechnology and pharmaceutical industries.

Read the full interview here.

 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Tags

Leave a Reply